# Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity

> **NCT06331806** · NA · UNKNOWN · sponsor: **European Institute of Oncology** · enrollment: 100 (estimated)

## Conditions studied

- Cardiomyopathy Due to Drug

## Interventions

- **DIAGNOSTIC_TEST:** Evaluation of myocardial fibrosis

## Key facts

- **NCT ID:** NCT06331806
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-22
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06331806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06331806, "Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06331806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*